Search Results
Managing toxicity post-CAR-T therapy in multiple myeloma
CAR T-Cells Multiple Myeloma: Adam Sperling, MD, PhD
An overview of the toxicities associated with immunotherapy in multiple myeloma
The curative potential of CAR-T therapy in multiple myeloma
Managing toxicities associated with immunotherapy in multiple myeloma
Managing CAR-T Cell Therapy in the Real World | Yi Lin, MD, PhD | IMS 2023
Management of CAR-T Toxicities: CRS, Neurological, Cytopenias, Infection
Managing Acute Toxicities of CAR T-cell Therapy
Dealing with Adverse Events and Toxicities in CAR-T
Managing CRS in myeloma
Dealing with Adverse Events and Toxicities in CAR-T
CAR-T therapy in multiple myeloma: research blind spots
